tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market

AbCellera Biologics (ABCL) Income Statement

Compare
1,710 Followers

AbCellera Biologics Income Statement

Last quarter (Q4 2024), AbCellera Biologics's total revenue was $5.05M, a decrease of -44.98% from the same quarter last year. In Q4, AbCellera Biologics's net income was $-34.21M. See AbCellera Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.83M$ 38.02M$ 485.42M$ 375.20M$ 233.16M
Gross Profit
$ 28.83M$ 38.02M$ 418.99M$ 329.69M$ 206.01M
Operating Expenses
$ 343.60M$ 275.23M$ 191.92M$ 107.79M$ 41.66M
Depreciation and Amortization
$ 97.00M$ 30.89M$ 33.10M$ 17.25M$ 5.27M
EBITDA
$ -204.15M$ -192.16M$ 272.20M$ 241.62M$ 169.62M
Operating Income
$ -314.77M$ -237.21M$ 216.51M$ 204.41M$ 156.03M
Other Income/Expenses
$ 114.37M$ 63.18M$ 22.59M$ 14.74M$ 1.80M
Pretax Income
$ -200.40M$ -174.03M$ 239.10M$ 219.15M$ 157.83M
Net Income
$ -162.86M$ -146.40M$ 158.52M$ 153.46M$ 118.92M
Per Share Metrics
Basic EPS
$ -0.55$ -0.51$ 0.56$ 0.56$ 0.44
Diluted EPS
$ -0.55$ -0.51$ 0.50$ 0.48$ 0.44
Weighted Average Shares Outstanding
294.33M 289.17M 285.06M 275.76M 269.50M
Weighted Average Shares Outstanding (Diluted)
294.33M 289.17M 314.83M 318.29M 269.50M
Currency in USD

AbCellera Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis